Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4808610A · kind A · utility
9Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 1986 |
| Grant date | Feb 28, 1989 |
| Priority date | — |
| Expiry date | Oct 2, 2006 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is an elegant, stable, self-preserving cream formulation containing mometasone furoate, 9.alpha., 21-dichloro-16.alpha.-methyl-1,4-pregnadiene-11.beta.,17.alpha.-diol-3,20- dione-17-(2'-furoate), useful as a topical anti-inflammatory product.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.